Back
Sarepta Therapeutics Vs. Vicor Industry Stock Comparison
Sell
37
SRPT
Sarepta Therapeutics
Last Price:
132.10
Seasonality Move:
9.41%
Buy
51
VICR
Vicor
Last Price:
46.41
Seasonality Move:
8.13%
Sell
37
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $129.88. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Vicor (VICR)
is a Buy
Is Vicor a Buy, Sell or Hold?
- The current Vicor [VICR] share price is $49.39. The Score for VICR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- VICR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $129.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
VICR Stock Price Chart
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 59.84 | Buy |
Chaikin Money Flow: | 345786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.92 - 127.2) | Buy |
Bollinger Bands (100): | (122.48 - 147.12) | Sell |
VICR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.68 | Buy |
Relative Strength Index (14 RSI): | 74.66 | Buy |
Chaikin Money Flow: | -61657 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.48 - 43.66) | Buy |
Bollinger Bands (100): | (34.23 - 40.53) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.4 | Buy |
20-day SMA: | 123.6 | Buy |
50-day SMA: | 128.94 | Buy |
200-day SMA: | 130.02 | Sell |
8-day EMA: | 126.58 | Buy |
20-day EMA: | 125.36 | Buy |
50-day EMA: | 128.32 | Buy |
200-day EMA: | 127.84 | Buy |
VICR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.96 | Buy |
20-day SMA: | 41.95 | Buy |
50-day SMA: | 39.05 | Buy |
200-day SMA: | 37.21 | Buy |
8-day EMA: | 43.83 | Buy |
20-day EMA: | 41.91 | Buy |
50-day EMA: | 39.8 | Buy |
200-day EMA: | 39.56 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.27 per share, and an increase next year of $8.99 per share.
Vicor Earnings Growth & VICR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.18 per share, and an increase next year of $0.69 per share.
Sarepta Therapeutics Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vicor Technical Analysis
Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |